Daniel Garcia

Daniel advises companies across biotechnology, pharmaceuticals, energy, infrastructure, oil and gas, consumer products, and industrial manufacturing on a wide range of commercial and operational contracts, aligning each agreement with business strategy throughout the corporate lifecycle—from structuring and growth to steady-state operations, transactional diligence, post-integration, and restructuring.

His experience spans the drafting and negotiation of foundational agreements and operational contracts that support business continuity across functions, as well as commercial arrangements that drive revenue, including master services agreements, manufacturing and supply contracts, distribution arrangements, licensing agreements, and strategic collaborations. In more specialized sectors, he has advised on project development and operations agreements, O&M contracts, EPC agreements, offtake arrangements, and other project-related contracts across upstream, midstream, and downstream operations.

Trained in both civil and common law systems, Daniel brings a practical, international perspective to cross-border contracting. He helps clients manage risk, navigate legal and regulatory complexity, and ensure that agreements are effective in practice and strategically aligned with long-term business objectives.

Prior to joining Baker McKenzie, Daniel advised clients on the following matters:

Life Sciences & Pharmaceuticals

• AlloVir, Inc. in the review and negotiation of multiple operational and commercial contracts relevant for its studies conducted in the United States, Europe, and Asia, including clinical trial agreements, research collaboration agreements, licensing agreements, master services agreements with contract research organizations, and manufacturing services agreements for clinical supply.
• A publicly traded immuno-oncology company in the review and negotiation of manufacturing services agreements for both clinical and commercial supply of its cancer-focused therapeutic product.
• A clinical-stage biopharmaceutical company focused on therapies for serious liver diseases in the negotiation of various operational and commercial agreements, including manufacturing services agreements, research collaboration agreements, consulting agreements, scientific advisory agreements, and agreements with contract research organizations.
• An AI-based medical imaging company focused on cardiovascular diagnostics in the review and negotiation of research collaboration agreements, clinical trial agreements, and master services agreements with CROs for studies conducted in the US and internationally.
• Bellicum Pharmaceuticals, a clinical-stage biopharmaceutical company in connection with the sale of its biomanufacturing facility.
• A clinical-stage biopharmaceutical company developing therapies for central nervous system cancers in the negotiation of various pre-clinical and clinical research and collaboration agreements, as well as master services agreements with CROs for studies conducted in the US and internationally.
• A global health-focused nonprofit organization in the negotiation of agreements with CROs for multi-country studies, coordinating closely with subject matter experts and local counsel across jurisdictions.
• Immatics US Inc. and Immatics Biotechnologies GmbH in the drafting and negotiation of a wide range of operational and strategic agreements, including material transfer agreements, clinical trial agreements, research collaboration agreements, licensing arrangements, and manufacturing and supply agreements supporting the development of their immunotherapies.
• ImmunoGenesis, Inc. in the negotiation of key commercial and development agreements supporting its immuno-oncology pipeline, including clinical trial agreements, research collaboration arrangements, consulting and advisory contracts, and manufacturing services agreements for its lead therapeutic candidates.
• March Biosciences, Inc. in the review and negotiation of manufacturing and development services agreements to support the production of its CAR-T cell therapy candidates, including arrangements for clinical supply and related operational support.
• A US-based research reactor facility affiliated with a public university in the negotiation of service agreements for the irradiation of materials used in the development of radiopharmaceuticals for cancer and other medical applications.
• Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing targeted radiotherapeutics for rare and difficult-to-treat cancers, in the negotiation of key clinical and development agreements, including clinical trial agreements and consulting arrangements aligned with its radiopharmaceutical pipeline.
• A radiopharmaceutical company focused on advancing cancer treatments through targeted radiation and imaging technologies in the drafting and negotiation of strategic and operational agreements, including research collaboration agreements and development services contracts, to support the delivery of precision therapies directly to tumor sites.

Other Industries

• Pemex Exploración y Producción: upstream contracts including exploration and production service agreements, oilfield service contracts, drilling and well services contracts, and equipment procurement and installation for exploration and wells.
• Pemex Refinación: downstream contracts including refinery EPC agreements, pipeline construction and operation contracts, maintenance service contracts, feedstock supply arrangements, and offtake agreements.
• Pemex Gas y Petroquímica Básica: midstream contracts including transportation agreements, storage and terminal agreements, and gas processing services arrangements.
• Pemex Petroquímica: EPC agreements for chemical plants, operations and maintenance agreements and supply contracts for feedstock and derivatives.
• Advised on multi-billion-dollar project management and project development agreements for a major infrastructure initiative in Saudi Arabia.
• A Texas-based energy services company in the negotiation of contracts for the sale, installation, and maintenance of refinery equipment in Mexico.
• Consumer and manufacturing clients in Latin America and the United States in the drafting and negotiation of cross-border manufacturing, supply, and distribution agreements.
• Additional project-related agreements, including long-term service arrangements, technology transfers, and operational contracts across industrial and infrastructure sectors.

• State Bar of Texas - Member
• The Florida Bar - Member
• The District of Columbia Bar - Member
• American Bar Association - Member